Study Objectives: Obstructive sleep apnea (OSA) is a well-established cause of impaired daytime functioning. However, there is a complex interindividual variability in neurobehavioral performance in OSA patients. We previously reported compromised brain bioenergetics during apneic sleep in severe OSA. In this study, we investigate whether brain bioenergetics during resting wakefulness are related to neurobehavioral performance.
Introduction
Obstructive sleep apnea (OSA) is a disorder characterized by episodes of partial or complete collapse of the upper airway during sleep, which results in repetitive periods of hypoxia with associated sleep fragmentation. It is associated with metabolic disorder, cardiac hypertrophy, increased risk of stroke, and poorer survival [1, 2] .
OSA presents a burgeoning public health problem with an increasing prevalence in the general population of 23%-50% rising in line with an obesity epidemic [3] . Recent Australian data found 38% of professional truck drivers have OSA [4] . This sleep disorder is associated with an estimated 1400 road fatalities, at a cost of $15.9 billion annually in the United States and exceeding $3 billion in Australia [5] . Patients with untreated OSA have a more than twofold increased risk of motor vehicle crashes [6] and workplace accidents [7] . Some patients report impaired daytime functioning in a number of cognitive domains including marked deficits in vigilance, as well as compromised performance on complex tasks such as a driving simulator test [8] . However, there is a significant inter-individual variability and no current robust clinical correlates for identifying those at greatest risk of performance deficits. When referenced to a "vulnerable" threshold of 2 SDs above the mean using simulated driving performance data from healthy controls, only a third of patients exhibit significant driving impairment and elevated accident risk [9] . Standard clinical characteristics show no or little predictive value for identifying those individuals at-risk of vigilance failure [9] . Several reviews and meta-analyses of structural and functional MRI data show significant structural atrophy and functional disturbances in the hippocampus and insular cortex highlighting the vulnerability of the brain in OSA [10] [11] [12] . Functional MRI studies in OSA have shown that altered cerebral responses during cognitive testing are dependent on the demands of the task and how certain brain regions are differentially affected [13] [14] [15] . A number of proton ( 1 H) MRS studies have demonstrated abnormalities in cerebral metabolites in OSA providing further evidence of hippocampal dysfunction and compromised frontal lobe integrity in this clinical population (for review see Xia et al. [16] ). Though there are a multitude of structural, functional and metabolic neuroimaging investigations in OSA, to our best knowledge, there are no phosphorus magnetic resonance spectroscopy ( 31 P MRS) studies which have examined brain mitochondrial oxidative phosphorylation markers and cognitive performance in OSA. This is particularly important given that the brain in untreated OSA is subjected to repeated periods of hypoxia followed by normoxia, which resemble ischemia-reperfusion events [17] .
In severe OSA, these events occur at least 30 times per hour and are often accompanied by a desaturation event with a dip in blood oxygen saturation levels of at least 3%-4% from baseline levels. In addition to the apnoeic insult, the brain in OSA suffers from repeated sleep disruption/fragmentation due to the need to be aroused from sleep sufficiently to open the upper airway. We previously reported a significant impact of apnea on brain bioenergetics during apneic sleep in patients with severe sleep-disordered breathing highlighting the vulnerability of the brain in OSA [18] . These data showed that the cerebrovascular compensatory mechanisms in response to oxygen desaturation events are inadequate to prevent decrements in brain high-energy phosphates. It is possible that compromised brain bioenergetics may in part underlie the neurobiological and neurobehavioral deficits in untreated OSA.
Several studies have reported altered cerebral metabolism in OSA using 1 H MRS [16] . For example, in one study the N-acetylaspartate/choline (NAA/Cho) ratio in cerebral white matter was significantly lower in moderate to severe OSA compared with mild OSA and healthy participants [19] . The finding of a decreased NAA/Cho ratio may reflect an increase in Cho due to membrane turnover or loss of the cell membrane, or may reflect a decrease in NAA which could occur due to loss of mitochondrial integrity or loss of actual neurons. Thus it is difficult to know whether this change reflected "cerebral metabolism" or reflected a histological change. In another study of severe OSA patients, levels of creatine (Cre), a bioenergetic marker [20] , were lower in the hippocampus, an area of the brain particularly susceptible to hypoxia, and levels were correlated with worse apnea severity and poorer PVT performance [21] . This study used 1 H MRS to measure brain Cre resonance using a long echo time which is sensitive to changes in Cre as well as its phosphorylation product, phosphocreatine (PCr). This approach may have been measuring changes in Cre/PCr or total Cre [22] . In contrast, 31 P MRS allows more direct measurement of brain energy status by quantifying high-energy phosphates and mitochondrial phosphorylation potential [23] . This is important because the brain mitochondria carry the bulk of the workload for buffering ATP (the brain's energy currency) during transient hypoxic events suggesting that the mitochondria may be particularly vulnerable in untreated OSA [18] . In healthy males, brain bioenergetic status has been linked to the speed of cognitive processing [24] with lower ratios of inorganic phosphate/ adenosine triphosphate (Pi/ATP) associated with faster cognitive speed. The Pi/ATP ratio is reflective of the steady state concentration of adenosine diphosphate (ADP), i.e. reflective of oxidative phosphorylation potential, (specifically, a higher Pi/ATP ratio is reflective of a lower phosphorylation potential) [23] . Efficient cognitive processing relies on the availability of adequate energy supply (namely ATP) to support the demands of the working brain. Oxidative phosphorylation provides the bulk of energy (ATP) for all of the major mechanisms which underlie brain information processing [25] . Investigating a patient's brain bioenergetics status may be a more accurate reflection of cognitive deficits/vulnerabilities in OSA.
In this study, we used 31 P MRS to investigate whether brain bioenergy metabolites during resting wakefulness are related to performance in cognitive functions known to be negatively affected in OSA. 31 P MRS was performed in the morning following one night of acute sleep deprivation and repeated neurobehavioral performance was assessed in the evening prior to and during the sleep deprivation period. Though the sleep deprivation aspect of this study was primarily to facilitate sleep in the scanner and examine the dynamics of brain bioenergetics during apnea [18] , we aimed to use this experimental paradigm to further our understanding of the mechanisms that underlie neurobehavioral impairment in OSA. Total and partial sleep deprivation experimental paradigms in sleep research have been extremely valuable in highlighting the wide variation in neurobehavioral performance among individuals and the stable trait-like differential vulnerability to the effects of sleep loss [26, 27] . Identifying predictors of this vulnerability and elucidating the mechanisms that underlie these trait-like differences is a critical avenue of research [28] , particularly for those sleep-disordered populations such as OSA where the consequences of performance error or impaired vigilance are potentially catastrophic. This study, therefore, aimed to examine brain bioenergetics markers previously shown to be compromised during apneic sleep in OSA [18] , and to test neurobehavioral performance under sleep-deprived conditions. The advantage of using a sleep deprivation experimental loading was to amplify the inter-individual variability in performance and expose the vulnerability of individuals [29] . Specifically, we hypothesized that increased Pi/ATP during resting wake would relate to impaired vigilance and simulated driving performance in patients with diagnosed untreated severe OSA. 
Methods

Participants and diagnostic polysomnography
Protocol and measurements
Patients attended the sleep laboratory at RPA Hospital in the evening and were kept awake overnight to facilitate them falling asleep in the magnetic resonance imaging (MRI) scanner by constant monitoring from 9 pm, and were studied using 31 P MRS at 7 am the following morning. Participants abstained from alcohol and caffeine for 24-hour before 31 P MRS. During the overnight sleep laboratory visit, participants rated their self-reported sleepiness using the Epworth sleepiness scale (ESS) [32] , and completed the Depression Anxiety Stress Scale (DASS-21) [33] , at 8 pm in the evening. Repeated performance testing on the 10-minute psychomotor vigilance task (PVT), a sustained attention test (Model PVT-192; CWE, Inc., Ardmore, Pennsylvania) [34] occurred at 9 pm, 11 pm, 1 am, 3 am, and 5 am. Performance testing on a 30-minute driving simulator task (AusEd Driving Simulator, Woolcock Institute of Medical Research, Sydney, Australia) [35] occurred at 9 pm and 5 am. Between performance test blocks, participants could read, play games, watch movies, and interact with the staff member who was monitoring them.
P MRS protocol
All spectra were acquired on a Philips (Best, The Netherlands) Intera 1.5 T scanner using a 10 cm 31 P surface coil placed over the temporal lobe ( Figure 1A ). Scans were acquired using a simple pulse and collect sequence with an adiabatic (sech) pulse to deliver increased depth penetration and signal to noise. Phase cycling was not used and data collection was started after eight dummy scans for attaining steady-state magnetization. Placement of the surface coil was checked by acquisition of an anatomic image to highlight the placement of the coil phantom relative to the patient and the coil shifted as required to ensure uniformity in coil placement across participants. There was no significant contribution to the signal from muscle, as assessed by the PCr/ATP ratio, from the fact that the images showed little muscle in the area, and the length of the chosen pulse that would have been more depth selective for brain tissue rather than surface muscle. This method was selected over alternatives using gradient or additive localization techniques because of the lack of gradient acoustic noise, the ability to pick up signal from the surface of the cortex, and the good signal to noise (and hence time resolution) obtainable by this approach. The temporal lobe was chosen over the alternative placement position for the coil (occipital lobe) because it was more comfortable for the participant (their head was not resting on a hard radiofrequency [RF] coil). The area sampled by the coil represented mostly temporal lobe with some contributions from inferior frontal and lateral anterior parietal lobe. A pulse oximeter was taped to the participant's finger and average resting (awake) saturation level recorded.
Before the participant fell asleep eight spectra were collected representing the awake, saturated state. The participant was kept awake by keeping the room illumination bright, playing music, and talking to the participant ensuring they responded to confirm wakefulness. The spectra comprised the sum of 16 transients, collected across 1024 data points with a duty cycle of 2 seconds and no phase cycling. The duration of each of the eight awake spectra was 48 seconds. The room was then darkened, the music turned off, and the participant was encouraged to fall asleep. Spectra were then collected as a time course of 160 single scan spectra with one spectrum every 2 seconds, co-recorded with pulse oximetry data. Typically, 10 full timecourses were acquired before the participant was removed from the magnet. The total scanning period did not exceed 70 minutes.
We have previously published data from this study which investigated brain bioenergetics during transient hypoxia in the same participants using spectra collected while asleep [18] . This secondary analysis examines only spectra collected during the resting awake state prior to participants falling asleep.
Analysis of MRS data
Spectra (N = 8 per subject) were obtained during the awake/alert period. These were processed as the sum of 16 transients. A typical spectrum is shown in Figure 1B . Spectra were processed using jMRUI (Version 2.1). Quantification of the reconstructed signals was performed in the time-domain. The AMARES algorithm was used to fit decaying sinusoids, corresponding to Lorentzian lineshapes in the frequency domain, to the resonances of phosphomonoesters (derived from phosphoethanolamine and phosphocholine), Pi, PCr, and the γ, α, and β peaks of ATP and the coil phantom. All fits were unconstrained apart from that of Pi, which was constrained to a line-width of 14 Hz to curtail any tendency to include broad baseline components in the fit of this sinusoid. The first-order phase correction estimated by AMARES was set to zero, and the first 20 points of the free induction decay (FID) weighted by multiplication with a quarter sine wave. Intracellular pH was also determined by jMRUI, using the frequency difference between Pi and PCr. Results were expressed as peak ratios, relative to total signal intensity (/Total P) and relative to the coil phantom (/Phantom). The β-ATP resonance was used for ATP estimation.
Our primary 31 P MRS outcome of interest was the Pi/ATP ratio, a marker of mitochondrial phosphorylation potential. ATP is the brain's major source of cellular energy and Pi levels reflect the use of Pi in the synthesis of the glycolytic intermediate glyceraldehyde-3-phosphate and its production through the hydrolysis of ATP and its steady-state levels inside the cell [23] . Secondary MRS outcomes were peak ratios of ATP relative to the coil phantom (ATP/Phantom) and the total signal intensity (ATP/Total P), as well as the peak ratios of PCr relative to ATP (PCr/ATP), PCr/Phantom, and PCr/Total P. Brain ATP levels are buffered by PCr, which is a high-energy phosphate molecule that acts as an energy reserve. PCr donates it phosphate group to ADP via the Cre kinase system to rapidly meet ATP demand. As part of this process any shortfall in ATP synthesis via mitochondrial oxidative phosphorylation leads to a decrease in PCr and increase free Cre and Pi [36] . These high-energy phosphates (ATP, Pi and PCr) involved in brain energy metabolism can be detected using the 31 P MRS technique [36] .
Statistical analysis
Correlation coefficients between PVT and driving performance variables and spectroscopy measures during resting wake were calculated using Pearson's correlation coefficient. 95% confidence intervals (CIs) were calculated by bootstrapping based on 1000 samples. Linear regression was used to calculate the variance (r 2 ) in performance outcomes explained by the spectroscopy variables. A priori we selected performance variables on tasks known to be sensitive to the effects of untreated OSA [9, 34] . On the PVT sustained attention task these were: reciprocal reaction time (PVT Mean RRT, ms), mean slowest 10% of RRTs (PVT mean slowest 10% RRT, rate per 1000 ms), and PVT lapses (response times greater than 500 ms). On the AusEd driving simulator task variables examined were braking reaction time (an average of the time taken to brake when trucks appear in the line of sight during the drive), lapses (reaction times of more than 3 seconds), crashes (i.e. driving off the shoulder of the road, hitting the back of a truck, or remaining stationary for more than 10 seconds) and steering deviation from the median lane position. Performance variables not normally distributed were mathematically transformed. PVT lapses were transformed for statistical analysis [(√n) + (√n + 1)] [37] . AusEd crashes were log-transformed [35] . Averaged performance across the testing period was derived from 5 × PVT test blocks (administered at 9 pm, 11 pm, 1 am, 3 am, 5 am), and 2 × AusEd driving tasks (9 pm and 5 am). We also examined correlations between performance and traditional measures of disease severity derived from diagnostic PSG including AHI (events/hour), EEG arousal index (events/hour) and oxygen saturation nadir (%) using parametric or nonparametric tests as appropriate. Post-hoc correlational analyses were also conducted to examine the relationship of sleepiness (ESS) and obesity (BMI) with performance measures and MRS metabolite ratios at the request of one of the anonymous reviewers. Case-wise regression diagnostics were performed to detect any potential outliers and high leverage data points. Studentized Residuals, Leverage and Cook's D values are presented in Supplementary Table S1 . Continuous variables are reported as mean ± SD unless otherwise stated. SPSS 22.0 for Windows (IBM SPSS, Somers, New York) was used for statistical analysis.
Results
Participants
We obtained resting awake spectra from 15 middle-aged, obese male patients with severe OSA. Patients were excessively sleepy (ESS score 13.2 ± 5.7) and diagnostic PSG showed fragmented sleep (EEG arousal index 70.1 ± 24.3 per hour of sleep) with a sleep efficiency of 75.4 ± 12.6%. See Table 1 for patient characteristics and overnight PSG metrics. The group median (min-max) of primary and secondary 
Associations between brain bioenergetics and performance
Associations between PSG measures of disease severity and performance
In contrast, the conventional PSG measures of disease severity including the AHI, EEG arousal index, and oxygen saturation nadir were not significantly correlated with any PVT or driving performance variable, see Table 2 .
Post-hoc analyses
In post-hoc analyses conducted self-rated sleepiness (ESS) or BMI did not significantly correlate with any performance measure, or MRS metabolite ratios (p > 0.05), see Supplementary  Table S1 .
Discussion
The current study is the first to investigate whether compromised brain bioenergetics measured by 31 P MRS during resting wakefulness is related to neurobehavioral dysfunction in untreated OSA. These results supported the hypothesis that an increased Pi/ATP ratio is related to impaired vigilance and poorer simulated driving performance in patients with untreated severe OSA. Significant associations between the primary measure of brain bioenergetics (Pi/ATP) and performance were consistently observed on both the 10-minutes sustained attention and 30-minutes simulated driving tasks. Moreover, significant associations were observed regardless of whether task performance was averaged across the testing period or when assessed at the individual testing time points of 9 pm, 11 pm, 1 am, 3 am, and 5 am. Analysis of secondary phosphorus metabolite ratios found a significant relationship between reduced ATP/Phantom ratio and impaired performance on both tasks; and increased PCr/ATP and PCr/Total P ratios were related to slower PVT reaction times. Taken together these resting state measures of brain bioenergetics indicated that reduced ATP was consistently related to worse performance.
Respiratory event-related indices during sleep are regularly reported in the literature as poor and inconsistent correlates of functional impairment in OSA [38, 39] . Similarly, in our study, the AHI, EEG arousal index, and oxygen saturation nadir, traditional PSG-derived measures of OSA severity, were not significantly related to any performance measure. Assessing risk of neurobehavioral impairment in patients with sleep apnea is challenging. For example, individuals with OSA are at greater risk of experiencing motor vehicle accidents [6] . However, only a small fraction of the crash risk is explained by clinical markers of OSA [9] . Identifying more robust biomarkers to supplement conventional PSG metrics is of great importance particularly for those known to work in high-risk, safety-critical occupations. The current study confirms that non-invasive 31 P MRS measurement of brain bioenergetics provides more accurate objective correlates of neurobehavioral dysfunction in untreated OSA than conventional PSG measures.
Sleep is thought to restore brain energy metabolites depleted by the energetic demands of wakefulness [40] . ATP is the primary currency of energy for the brain and PCr is used as an energy buffer. ATP levels are maintained at a steady-state during wakefulness but surge in the initial hours of sleep returning to baseline at the end of the sleep period [41] . The intricate interplay of the metabolic cycles involved in ATP synthesis and its subsequent depletion, and the compensatory buffering by Cre kinase to readily mobilize high-energy metabolites ensure that cerebral energy levels are maintained and stable for efficient brain functioning. The brain has a high metabolic demand and no oxygen storage capacity. It is therefore highly sensitive to restrictions in its oxygen supply, which can chronically occur during sleep each night in sufferers of OSA [17] . We previously showed that transient periods of hypoxia during sleep resulted in significant changes in brain energy metabolism with falls in brain ATP levels and increases in Pi without concomitant changes in PCr or brain pH [18] . In the normoxic, awake working brain ATP levels usually remain relatively constant by using PCr as an energy reserve. However, during hypoxic episodes in untreated OSA patients, ATP synthesis appears to suddenly cease probably due to hypoxic mitochondria and an inadequate buffering by mitochondrial Cre kinase. The functional consequences of these dynamic changes in brain bioenergetics during sleep are unclear however we speculate that adaptive brain bioenergetics may protect a patient from the insult of repetitive hypoxia. It is possible that those individuals that return to a higher resting phosphorylation potential (reflected by a lower Pi/ ATP ratio) following a period of transient hypoxia may also have more efficient neurobehavioral functioning. This may explain why some OSA patients are more vulnerable to the detrimental effects of OSA on neurobehavioral functioning compared with others. We note that as we have not examined a control group, we cannot be certain if the relationships demonstrated are specific to OSA. Measuring high-energy phosphates during resting wake provides information about the efficiency of the brain's ability to respond to cognitive challenges. Data in healthy young adults show that lower Pi/ATP during wake significantly relates to superior information processing during cognitive testing [24] . Notably, the current findings in patients with severe OSA show that higher Pi/ATP during resting wake was significantly related to worse performance. To our knowledge, there are no other published studies in OSA which examine brain energetics in the awake brain using 31 P MRS. In addition to experiencing intermittent hypoxia each night, patients with OSA also have significantly fragmented sleep. This may be present for many years in an untreated state and how this impacts on brain bioenergetics status remains unclear. Acute sleep deprivation 31 P MRS studies show how sleep deprivation delays the sleep-related increase in ATP with no significant change in brain bioenergetics relative to baseline sleep [42] [43] [44] . Subsequent recovery sleep found marked changes in brain chemistry with increases in β-nucleoside triphosphate (NTP) (proportional to ATP) and γ-NTP, total NTP and PCr, suggesting part of the brain's recovery after sleep loss involves increases in high-energy phosphates which primarily occur in grey-matter [44] . However, untreated OSA patients do not have the opportunity to fully restore their sleep and recover due to the impact of ongoing hypoxic insults and disrupted sleep. Patients with primary insomnia have been shown to have brain metabolic profiles indicative of metabolic exhaustion indicating that chronic partial sleep deprivation has metabolic consequences [45] . How disease chronicity and reduced sleep quality directly contribute to disrupted brain bioenergetics and neurobehavioral deficits in OSA is also unclear. It is possible that the cumulative effects of chronic sleep loss in untreated OSA disrupt the restorative processes of sleep and compromise brain energetics [46] . Patients with sleep apnea may have different brain bioenergetics responses to hypoxia. Healthy awake volunteers undergoing mild transient (5 minutes) hypoxia during wakefulness have shown no alterations in brain bioenergetics on that time scale [47] . This may be due to better cerebrovascular reactivity in healthy controls compared to patients with OSA, who have impaired cerebrovascular reactivity, even when awake [48] . It is possible that the combination of sleep fragmentation and repetitive hypoxia combined with poor vascular reactivity adversely affects brain bioenergetics, which in turn, has deleterious effects on tasks requiring speed of processing and vigilance.
This study has several limitations. We sampled a large brain region using 31 P MRS to noninvasively measure the global response of high-energy phosphates rather than focusing on a specific, localized brain region. Sampling of a large brain region is essential for optimizing the signal-to-noise ratio allowing us to measure dynamic changes in brain energetics every 2 seconds. As part of the protocol the OSA patients were kept awake overnight prior to the scanning in the morning where the bioenergetics status of the brain was measured following acute sleep deprivation. Patients were not studied in a well-rested state and we cannot ascertain whether the observed relationship between 31 P measures and performance is only due to the presence of sleep deprivation. In healthy, rested, adults there a similar relationship between Pi/ATP and performance was observed [24] . Experimental sleep deprivation amplifies the inter-individual variability in performance decrements revealing trait-like vulnerability characteristics of healthy and OSA participants [26, 49] . This approach is a strength of the current study and is likely to have increased our ability to detect the correlations of interest. If sleep deprivation indeed amplified alterations in bioenergetics, the utility of this measure as a disease biomarker may be limited in a clinical setting. 31 P MRS data in healthy adults shows a similar range of variability in brain metabolites pre and post sleep deprivation [42, 44] . Future studies examining brain bioenergetics in OSA patients and controls, pre and post sleep deprivation with performance testing are therefore warranted.
An a priori statistical power calculation was not conducted as these analyses were secondary to the primary aim of the study. Although we did not correct for multiple correlations all associations between our primary measure of brain bioenergetics and performance are all in the same direction, suggesting a consistent pattern. To further verify the data quality we looked at secondary ATP measures, and again found consistent patterns. Simultaneous EEG recording to verify wakefulness was not undertaken during the acquisition of the resting wake spectra as this capability was not available at that time. We regularly talked to the patient who was required to respond periodically to confirm they were awake. The diagnostic PSG data was not collected the night immediately prior to the experimental protocol which may have contributed to a lack of significant associations with neurobehavioral performance measures. However, the inconsistent correlations between traditional PSG metrics and neurobehavioral outcomes in OSA studies are widely acknowledged [50] , and alternative measures are a priority [51] .
In summary, this is the first 31 P MRS study to show that a higher Pi/ATP ratio, reflecting lower phosphorylation potential, in the temporal lobe during resting wake is consistently related to worse performance in patients with severe OSA. The temporal lobe is one of the first regions affected in dementia with the pathological build-up of neurofibrillary tangles in the early stages of Alzheimer's disease [52] . Recent research has identified untreated OSA as a significant risk factor for developing mild cognitive impairment or dementia [53] . Early changes in brain energy metabolites detected using noninvasive 31 P MRS may provide new biomarkers of neural injury in OSA and identify those individuals at greater risk of cognitive decline and neurodegeneration. Studies in larger patient numbers are required to elucidate the impact of brain bioenergetics on longer-term clinical outcomes in OSA. Future research to investigate the role of neuro-protectant therapies such as Cre supplementation, either as an adjunct to CPAP treatment or as a stand-alone therapy in selected patients, is potentially the next step to improve brain bioenergetics in OSA patients [20] , in whom brain Cre levels are known to be low and are associated with neurobehavioral deficits [21] . Future work must also identify more sensitive alternative markers than the traditional AHI to further elucidate the impact of OSA on the brain and to accurately assess patients' response to novel treatments [51] . In conclusion, measuring brain bioenergetics during resting wake in OSA may be a more reliable predictor of vigilance and attention deficits than traditional PSG measures of disease severity.
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